These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7277385)

  • 1. Inhibition of dihydrofolate reductase: structure-activity correlations of quinazolines based upon molecular shape analysis.
    Battershell C; Malhotra D; Hopfinger AJ
    J Med Chem; 1981 Jul; 24(7):812-8. PubMed ID: 7277385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of dihydrofolate reductase: structure-activity correlations of 2,4-diamino-5-benzylpyrimidines based upon molecular shape analysis.
    Hopfinger AJ
    J Med Chem; 1981 Jul; 24(7):818-22. PubMed ID: 7277386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined distance geometry analysis of dihydrofolate reductase inhibition by quinazolines and triazines.
    Ghose AK; Crippen GM
    J Med Chem; 1983 Jul; 26(7):996-1010. PubMed ID: 6864738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dihydrofolate reductase. Structure-activity correlations of quinazolines.
    Fukunaga JY; Hansch C; Steller EE
    J Med Chem; 1976 May; 19(5):605-11. PubMed ID: 1271401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity relationship by distance geometry: quinazolines as dihydrofolate reductase inhibitors.
    Ghose AK; Crippen GM
    J Med Chem; 1982 Aug; 25(8):892-9. PubMed ID: 7120278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular shape analysis and quantitative structure-activity relationship investigation of some triazine-antifolate inhibitors of Leishmania dihydrofolate reductase.
    Koehler MG; Rowberg-Schaefer K; Hopfinger AJ
    Arch Biochem Biophys; 1988 Oct; 266(1):152-61. PubMed ID: 3178219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
    Hansch C; Fukunaga JY; Jow PY
    J Med Chem; 1977 Jan; 20(1):96-102. PubMed ID: 319234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General distance geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors.
    Ghose AK; Crippen GM
    J Med Chem; 1984 Jul; 27(7):901-14. PubMed ID: 6737433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size.
    Kuyper LF; Baccanari DP; Jones ML; Hunter RN; Tansik RL; Joyner SS; Boytos CM; Rudolph SK; Knick V; Wilson HR; Caddell JM; Friedman HS; Comley JC; Stables JN
    J Med Chem; 1996 Feb; 39(4):892-903. PubMed ID: 8632413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinazolines as inhibitors of dihydrofolate reductase. 1.
    Ashton WT; Walker FC; Hynes JB
    J Med Chem; 1973 Jun; 16(6):694-7. PubMed ID: 4715004
    [No Abstract]   [Full Text] [Related]  

  • 11. Quinazolines as inhibitors of dihydrofolate reductase. 4. Classical analogues of folic and isofolic acids.
    Hynes JB; Eason DE; Garrett CM; Colvin PL
    J Med Chem; 1977 Apr; 20(4):588-91. PubMed ID: 850245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative structure-activity relationship of triazine-antifolate inhibition of Leishmania dihydrofolate reductase and cell growth.
    Booth RG; Selassie CD; Hansch C; Santi DV
    J Med Chem; 1987 Jul; 30(7):1218-24. PubMed ID: 3599028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CoMFA and CoMSIA analyses of Pneumocystis carinii dihydrofolate reductase, Toxoplasma gondii dihydrofolate reductase, and rat liver dihydrofolate reductase.
    Gangjee A; Lin X
    J Med Chem; 2005 Mar; 48(5):1448-69. PubMed ID: 15743188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 7. Analysis of the effect of 3,5-dialkyl substituent size and shape on binding to four different dihydrofolate reductase enzymes.
    Roth B; Rauckman BS; Ferone R; Baccanari DP; Champness JN; Hyde RM
    J Med Chem; 1987 Feb; 30(2):348-56. PubMed ID: 3100802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinazolines as inhibitors of dihydrofolate reductase. 2.
    Hynes JB; Ashton WT
    J Med Chem; 1974 Sep; 17(9):1023-5. PubMed ID: 4213339
    [No Abstract]   [Full Text] [Related]  

  • 16. A general QSAR for dihydrofolate reductase inhibition by 2,4-diaminotriazines based upon molecular shape analysis.
    Hopfinger AJ
    Arch Biochem Biophys; 1981 Jan; 206(1):153-63. PubMed ID: 7212714
    [No Abstract]   [Full Text] [Related]  

  • 17. Antifolate and antibacterial activities of 5-substituted 2,4-diaminoquinazolines.
    Harris NV; Smith C; Bowden K
    J Med Chem; 1990 Jan; 33(1):434-44. PubMed ID: 2404122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydrofolate reductase inhibition. A study in the use of X-ray crystallography, molecular graphics, and quantitative structure-activity relations in drug design.
    Hansch C
    Drug Intell Clin Pharm; 1982 May; 16(5):391-6. PubMed ID: 6806055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional molecular shape analysis-quantitative structure-activity relationship of a series of cholecystokinin-A receptor antagonists.
    Tokarski JS; Hopfinger AJ
    J Med Chem; 1994 Oct; 37(21):3639-54. PubMed ID: 7932591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
    Chello PL; McQueen CA; DeAngelis LM; Bertino JR
    Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.